The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000791336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
6/06/2026
Date registered
Help: Date registered
1/07/2026
Date last updated
Help: Date last updated
1/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
1/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Virtual Emergency Department Short-Stay Unit for infants with mild bronchiolitis: a non-inferiority randomised controlled trial of hospital-level care at home using remote patient monitoring to assess oxygen therapy, acceptability and cost outcomes
Scientific title
Virtual Emergency Department Short-Stay Unit for infants with mild bronchiolitis: a non-inferiority randomised controlled trial of hospital-level care at home using remote patient monitoring to assess oxygen therapy, acceptability and cost outcomes
Additional trial identifiers [1] 317510 0
nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Bronchiolitis 342248 0
Condition category
Condition code
Respiratory 338363 338363 0 0
Other respiratory disorders / diseases
Public Health 338629 338629 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is a virtual Emergency Department Short-Stay Unit (EDSSU) admission, delivered as an alternative to physical EDSSU admission for infants with mild bronchiolitis who have been assessed in the Emergency Department as requiring short-stay observation. The intervention provides hospital-level observation and clinical support at home through wearable remote patient monitoring, scheduled audiovisual nursing reviews, daily paediatrician-led virtual ward rounds, 24/7 access to clinical support, and clear escalation pathways back to hospital if required.

Care is delivered by the virtualKIDS nursing and medical team, with oversight from paediatricians experienced in paediatric acute care and virtual models of care. The intervention is delivered individually to each participant in their home using audiovisual telehealth, telephone support when required, and continuous wearable remote monitoring.

Each infant allocated to the virtual EDSSU arm will be fitted with the Masimo SafetyNetâ„¢/Radius PPGâ„¢ remote patient monitoring system. The Masimo Radius PPGâ„¢ sensor/probe is applied to an appropriate peripheral site according to manufacturer instructions and local clinical training. The device connects to the Masimo SafetyNetâ„¢ application and supports remote monitoring of oxygen saturation, heart rate and respiratory rate by the virtualKIDS team. Families are provided with education on device use, probe positioning, troubleshooting, expected observations, and when to contact the virtualKIDS team. A backup Masimo Radius PPGâ„¢ probe is provided in case the primary probe fails, dislodges or cannot provide reliable readings.

The monitoring system is used continuously for the duration of the virtual EDSSU admission, with alerts and prompts available to parents/carers and clinicians in the virtualKIDS Command Hub. Continuous monitoring is complemented by scheduled 4-hourly reviews, including a full audiovisual assessment by a trained virtualKIDS nurse. These reviews include assessment of heart rate, respiratory rate, oxygen saturation, work of breathing and hydration, aligned with usual paediatric observation and escalation processes. Infants also receive a daily paediatrician-led virtual ward round.

The intervention begins after consent, randomisation and allocation to the virtual EDSSU arm, once the infant has been assessed in the Emergency Department as requiring EDSSU-level observation. Monitoring commences when the infant is discharged home under the virtual EDSSU model and continues until the infant is clinically ready for discharge or requires escalation to hospital-based care. A final face-to-face Acute Review Clinic appointment is used for discharge assessment and device removal, unless the infant is escalated earlier for hospital assessment.

Parents/carers have 24/7 access to the virtualKIDS clinical support line and may self-escalate at any time if they are concerned. Adherence and safety are supported through parent/carer education, continuous remote monitoring, scheduled 4-hourly clinical reviews, device alerts, backup equipment, a 24/7 support line and predefined escalation criteria. If the device, application, probe, internet connection or audiovisual connection cannot be restored, or if the infant cannot be safely monitored for more than four hours, this is treated as a technology failure and the infant is directed to return for hospital assessment.

Remote patient monitoring is used as an enabling technology; the study is evaluating the virtual EDSSU model of care, rather than the device alone. The study will assess whether the virtual EDSSU model is non-inferior to physical EDSSU admission. The primary outcome is the proportion of participants requiring oxygen therapy within 7 days of randomisation. Secondary outcomes include length of stay, ED re-presentation, admission or transfer to physical care, adverse events, technology failure, parent/carer confidence and preparedness, acceptability to families and clinicians, and health-system and family costs.
Intervention code [1] 334302 0
Treatment: Other
Description of the comparator or control
The comparator is standard care through physical admission to the Emergency Department Short-Stay Unit (EDSSU).

Infants randomised to the control arm will remain in hospital and receive usual EDSSU care for mild bronchiolitis. Care is delivered face to face by the EDSSU nursing and medical team, including bedside nursing observations and medical review as clinically required. Observations include heart rate, respiratory rate, work of breathing, oxygen saturation and hydration status.

Participants in the physical EDSSU arm will receive 4-hourly clinical observations and daily paediatrician review, consistent with usual EDSSU care. Parents and carers can escalate concerns directly to the bedside nursing or medical team while the infant remains in hospital.

The comparator is delivered in the hospital EDSSU setting at the participating study sites. Participants remain in the physical EDSSU until they are clinically ready for discharge, according to standard hospital discharge criteria. Discharge occurs after in-person clinical review. Clinical outcomes, safety events, length of stay, re-presentation, parent/carer experience and cost-related data will be collected for comparison with the virtual EDSSU intervention arm.
Control group
Active

Outcomes
Primary outcome [1] 345679 0
Need for oxygen therapy
Timepoint [1] 345679 0
Within 7 days of randomisation
Secondary outcome [1] 462844 0
Length of stay
Timepoint [1] 462844 0
From randomisation to discharge from the allocated model of care
Secondary outcome [2] 462845 0
Emergency department re-presentation
Timepoint [2] 462845 0
Within 7 days of randomisation
Secondary outcome [3] 462846 0
This will be assessed as a composite outcome. The composite outcome includes transfer from virtual EDSSU care to physical emergency department or short-stay hospital care, admission to a physical Emergency Department Short-Stay Unit, or inpatient ward admission. This will be determined by review of the participant’s medical record, virtualKIDS clinical records and hospital admission records.
Timepoint [3] 462846 0
Within 7 days of randomisation
Secondary outcome [4] 462847 0
Unplanned virtual clinical reviews
Timepoint [4] 462847 0
During the virtual emergency department short-stay unit admission
Secondary outcome [5] 462848 0
Adverse events
Timepoint [5] 462848 0
Within 7 days of randomisation
Secondary outcome [6] 462849 0
Technology failure
Timepoint [6] 462849 0
During the virtual emergency department short-stay unit admission
Secondary outcome [7] 462850 0
Parent or carer confidence and preparedness
Timepoint [7] 462850 0
At baseline/allocation and 48 hours to 7 days after discharge or transfer
Secondary outcome [8] 462851 0
Parent or carer anxiety
Timepoint [8] 462851 0
At baseline/allocation and 48 hours to 7 days after discharge or transfer
Secondary outcome [9] 462852 0
Parent or carer experience and acceptability
Timepoint [9] 462852 0
48 hours to 7 days after discharge or transfer
Secondary outcome [10] 462853 0
Clinician experience and acceptability
Timepoint [10] 462853 0
Any time from commencement of the trial
Secondary outcome [11] 462854 0
Health-system cost of care
Timepoint [11] 462854 0
From randomisation to 7 days after randomisation
Secondary outcome [12] 462855 0
Family and societal cost of care
Timepoint [12] 462855 0
48 hours to 7 days after discharge or transfer

Eligibility
Key inclusion criteria
1. Infant aged 3 months to less than 12 months, corrected age.
2. Presenting to the Emergency Department with mild bronchiolitis, as defined by the PREDICT bronchiolitis guideline.
3. Assessed by the treating Emergency Department doctor as requiring Emergency 4. Department Short-Stay Unit admission for observation.
5. Parent or legal guardian is able to provide written informed consent.
6. Parent or legal guardian is willing for the infant to be randomised to either physical
7. Emergency Department Short-Stay Unit care or virtual Emergency Department Short-Stay Unit care at home.
8. For infants allocated to the virtual care arm, the family must have reliable internet connectivity through wireless or cellular network, and be able to return to hospital for in-person review or escalation if required.
9. For infants allocated to the virtual care arm, the family must be able to attend a final in-person Acute Review Clinic appointment for discharge assessment and device removal.
Minimum age
3 Months
Maximum age
12 Months
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Unclear diagnosis at presentation.
2. Chronic medical condition or other clinical safety concern, including but not limited to congenital heart disease or chronic lung disease.
3. Gestational age less than 37 weeks.
4. Any concern regarding child safety or welfare.
5. Requirement for oxygen supplementation after Emergency Department observation.
6. Requirement for intravenous antibiotics or ongoing nasogastric or intravenous rehydration.
7. Does not live within one hour’s drive of the hospital.
8. Poor or unreliable internet connectivity that cannot be resolved by the study team or the parent/legal guardian, for participants allocated to the virtual care arm.
9. Previously recruited to the study.
10. Practical barriers that cannot be reasonably addressed and would prevent safe home monitoring or timely return to hospital if escalation is required.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation will be concealed using REDCap. The randomisation sequence will be generated by an independent statistician not involved in recruitment or study delivery. Recruiters will only receive the group allocation in REDCap after eligibility has been confirmed, informed consent has been obtained, and the participant has been enrolled. Upcoming allocations will be concealed from study personnel.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A computer-generated randomisation sequence will be prepared by an independent statistician. Participants will be randomised in a 1:1 ratio to either the virtual EDSSU intervention arm or the physical EDSSU control arm. Randomisation will use permuted blocks of varying size, including block sizes of two, four and six.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
The sample size is based on a two-arm non-inferiority randomised controlled trial comparing virtual EDSSU care at home with standard physical EDSSU admission. Participants will be randomised in a 1:1 allocation ratio. The primary outcome is the proportion of participants requiring oxygen therapy within 7 days of randomisation. Assuming no true difference between groups, an estimated primary outcome event rate of 30% in both arms, an absolute non-inferiority margin of 13 percentage points, 80% power, and a one-sided 95% confidence interval equivalent to a two-sided 90% confidence interval, 308 participants are required, with 154 participants per arm. Allowing for 5% attrition or withdrawal gives a total sample size of 326 participants, with 163 participants per arm. Non-inferiority will be declared if the upper limit of the confidence interval for the difference in proportions requiring oxygen therapy between the virtual EDSSU and physical EDSSU arms does not exceed 13 percentage points. Analyses will include intention-to-treat and per-protocol analyses.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 322077 0
Government body
Name [1] 322077 0
Translational Research Grants Scheme, administered by Ministry of Health NSW
Country [1] 322077 0
Australia
Primary sponsor type
Government body
Name
Sydney Children's Hospital Network
Address
Country
Australia
Secondary sponsor category [1] 324963 0
None
Name [1] 324963 0
Address [1] 324963 0
Country [1] 324963 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320608 0
Sydney Children's Hospitals Network Human Research Ethics Committee
Ethics committee address [1] 320608 0
Ethics committee country [1] 320608 0
Australia
Date submitted for ethics approval [1] 320608 0
28/03/2026
Approval date [1] 320608 0
16/06/2026
Ethics approval number [1] 320608 0
026/ETH00656

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151038 0
Dr Jagdev Singh
Address 151038 0
virtualKIDS, Level 2, The Children's Hospital at Westmead, Cnr Hawkesbury and Hainsworth Street, Westmead, NSW 2145
Country 151038 0
Australia
Phone 151038 0
+61437325842
Fax 151038 0
Email 151038 0
Contact person for public queries
Name 151039 0
Jagdev Singh
Address 151039 0
virtualKIDS, Level 2, The Children's Hospital at Westmead, Cnr Hawkesbury and Hainsworth Street, Westmead, NSW 2145
Country 151039 0
Australia
Phone 151039 0
+61437325842
Fax 151039 0
Email 151039 0
Contact person for scientific queries
Name 151040 0
Jagdev Singh
Address 151040 0
virtualKIDS, Level 2, The Children's Hospital at Westmead, Cnr Hawkesbury and Hainsworth Street, Westmead, NSW 2145
Country 151040 0
Australia
Phone 151040 0
+61437325842
Fax 151040 0
Email 151040 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.